Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607)
China
· Delayed Price · Currency is CNY
20.91
-0.23 (-1.09%)
Nov 13, 2024, 3:00 PM CST
Shanghai Pharmaceuticals Holding Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 33,823 | 30,518 | 27,401 | 22,390 | 22,354 | 18,200 | Upgrade
|
Trading Asset Securities | 8,563 | 10,152 | 9,614 | - | - | - | Upgrade
|
Cash & Short-Term Investments | 42,385 | 40,670 | 37,015 | 22,390 | 22,354 | 18,200 | Upgrade
|
Cash Growth | 4.22% | 9.87% | 65.32% | 0.16% | 22.83% | -5.95% | Upgrade
|
Accounts Receivable | 86,054 | 77,163 | 70,187 | 61,006 | 55,522 | 49,801 | Upgrade
|
Other Receivables | 3,240 | 2,373 | 1,957 | 1,786 | 1,343 | 1,518 | Upgrade
|
Receivables | 89,294 | 79,536 | 72,144 | 62,791 | 56,865 | 51,319 | Upgrade
|
Inventory | 37,576 | 36,623 | 34,460 | 27,104 | 24,088 | 24,877 | Upgrade
|
Other Current Assets | 4,532 | 5,605 | 5,894 | 4,209 | 4,255 | 3,695 | Upgrade
|
Total Current Assets | 173,788 | 162,434 | 149,513 | 116,494 | 107,563 | 98,092 | Upgrade
|
Property, Plant & Equipment | 18,726 | 18,302 | 16,550 | 15,793 | 14,626 | 13,128 | Upgrade
|
Long-Term Investments | 10,381 | 10,603 | 11,477 | 10,836 | 7,663 | 5,432 | Upgrade
|
Goodwill | 11,408 | 11,393 | 11,336 | 11,239 | 11,342 | 10,790 | Upgrade
|
Other Intangible Assets | 5,754 | 6,070 | 6,263 | 6,049 | 5,195 | 3,930 | Upgrade
|
Long-Term Deferred Tax Assets | 1,805 | 1,717 | 1,535 | 1,368 | 1,359 | 1,223 | Upgrade
|
Long-Term Deferred Charges | 220.2 | 310.51 | 342.61 | 259.23 | 639.15 | 606.39 | Upgrade
|
Other Long-Term Assets | 1,660 | 1,143 | 1,119 | 1,397 | 797.64 | 3,825 | Upgrade
|
Total Assets | 223,741 | 211,973 | 198,135 | 163,436 | 149,186 | 137,026 | Upgrade
|
Accounts Payable | 61,688 | 54,632 | 51,566 | 41,995 | 37,792 | 36,872 | Upgrade
|
Accrued Expenses | 1,591 | 10,638 | 9,574 | 7,985 | 6,816 | 5,405 | Upgrade
|
Short-Term Debt | 45,017 | 41,612 | 33,811 | 31,592 | 25,158 | 23,139 | Upgrade
|
Current Portion of Long-Term Debt | 1,927 | 2,366 | 2,649 | 33.44 | 8,311 | 624.86 | Upgrade
|
Current Portion of Leases | - | 596.67 | 580.68 | 545.04 | 574.57 | 560.87 | Upgrade
|
Current Income Taxes Payable | 952.11 | 809.8 | 781.36 | 721.16 | 682.45 | 716.99 | Upgrade
|
Current Unearned Revenue | 1,442 | 1,971 | 2,243 | 1,311 | 1,311 | 1,534 | Upgrade
|
Other Current Liabilities | 16,916 | 9,747 | 9,487 | 7,642 | 7,488 | 5,755 | Upgrade
|
Total Current Liabilities | 129,532 | 122,372 | 110,691 | 91,824 | 88,133 | 74,608 | Upgrade
|
Long-Term Debt | 7,690 | 5,786 | 6,260 | 7,158 | 1,184 | 9,134 | Upgrade
|
Long-Term Leases | 1,619 | 1,550 | 1,302 | 1,434 | 1,501 | 1,156 | Upgrade
|
Long-Term Unearned Revenue | 589.68 | 633.48 | 534.58 | 2,349 | 2,224 | 1,279 | Upgrade
|
Long-Term Deferred Tax Liabilities | 876.71 | 1,016 | 1,049 | 998.77 | 832.38 | 809.6 | Upgrade
|
Other Long-Term Liabilities | 251.34 | 250.14 | 257.26 | 566.09 | 570.39 | 654.6 | Upgrade
|
Total Liabilities | 140,584 | 131,646 | 120,132 | 104,369 | 94,445 | 87,640 | Upgrade
|
Common Stock | 3,705 | 3,703 | 3,698 | 2,842 | 2,842 | 2,842 | Upgrade
|
Additional Paid-In Capital | - | 29,188 | 29,098 | 16,071 | 15,898 | 15,721 | Upgrade
|
Retained Earnings | 38,368 | 36,129 | 34,639 | 30,591 | 26,880 | 23,639 | Upgrade
|
Comprehensive Income & Other | 28,793 | -496.09 | -371.32 | -144.39 | -265.41 | -542.23 | Upgrade
|
Total Common Equity | 70,866 | 68,524 | 67,063 | 49,359 | 45,355 | 41,659 | Upgrade
|
Minority Interest | 12,292 | 11,802 | 10,939 | 9,707 | 9,386 | 7,727 | Upgrade
|
Shareholders' Equity | 83,158 | 80,326 | 78,002 | 59,066 | 54,741 | 49,386 | Upgrade
|
Total Liabilities & Equity | 223,741 | 211,973 | 198,135 | 163,436 | 149,186 | 137,026 | Upgrade
|
Total Debt | 56,253 | 51,911 | 44,602 | 40,762 | 36,728 | 34,614 | Upgrade
|
Net Cash (Debt) | -13,867 | -11,241 | -7,587 | -18,372 | -14,374 | -16,415 | Upgrade
|
Net Cash Per Share | -3.72 | -3.04 | -2.18 | -6.46 | -5.06 | -5.78 | Upgrade
|
Filing Date Shares Outstanding | 3,705 | 3,703 | 3,698 | 2,842 | 2,842 | 2,842 | Upgrade
|
Total Common Shares Outstanding | 3,705 | 3,703 | 3,698 | 2,842 | 2,842 | 2,842 | Upgrade
|
Working Capital | 44,256 | 40,062 | 38,822 | 24,670 | 19,430 | 23,484 | Upgrade
|
Book Value Per Share | 19.13 | 18.50 | 18.14 | 17.37 | 15.96 | 14.66 | Upgrade
|
Tangible Book Value | 53,704 | 51,061 | 49,464 | 32,071 | 28,817 | 26,939 | Upgrade
|
Tangible Book Value Per Share | 14.50 | 13.79 | 13.38 | 11.28 | 10.14 | 9.48 | Upgrade
|
Buildings | - | 11,460 | 10,941 | 9,698 | 9,351 | 8,480 | Upgrade
|
Machinery | - | 10,035 | 9,054 | 8,203 | 7,743 | 6,799 | Upgrade
|
Construction In Progress | - | 3,570 | 2,777 | 2,914 | 1,737 | 1,650 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.